期刊文献+

多药耐药相关蛋白在乳腺癌患者外周血单个核细胞中的表达研究 被引量:3

Expressions of multidrug resistanc-associated protein in peripheral blood mononuclear cells in patients with breast cancer
下载PDF
导出
摘要 目的检测健康人和乳腺癌患者外周血单个核细胞中多药耐药相关蛋白(multidrug resistance-associated protein,MRP)基因的表达水平,探讨MRP在乳腺癌患者中的可能作用。方法抽取20例健康人和50例乳腺癌患者外周血,运用ELISA法检测2组实验对象血清中肿瘤坏死因子α(TNF-α)、白介素-8(IL-8)、白介素6(IL-6)细胞因子的含量;提取外周血中单个核细胞(Peripheral blood monouclear cells,PBMCs),后用荧光实时定量PCR和Western blot技术检测BCRP和MRP2/3/4/5 mRNA和相应蛋白表达情况。结果 ELISA法检测乳腺癌患者外周血血清中TNF-α、IL-8、IL-6细胞因子的含量明显高于健康人对照组(P<0.05);荧光实时定量PCR检测BCRP和MRP5的mRNA表达水平高于健康人对照组(P<0.05),其余MRP没有显著性差别(P>0.05);Western blot检测蛋白表达与mRNA结果一致。结论乳腺癌患者外周血中的促炎因子含量的升高与BCRP和MRP5的表达调控有一定关系,具体相关机制有待进一步研究。 Objective To investigate the expression of multidrug resistance-associated protein ( MRP) in peripheral blood monouclear cells ( PBMCs) of healthy people and patients with breast cancer ,and to explore their possible roles in the pathogenesis of breast cancer .Methods The levels of TNF-α,IL-8 and IL-6 in serum were detected by ELISA in 50 patients with breast cancer ( patients group ) and 20 healthy subjects ( control group ) .After the PBMCs in both groups were extracted , the expression levels of breast cancer resistance protein ( BCRP ) and MRP2/3/4/5 mRNA were detected by Real-time quantitative RT-PCR and Western blotting .Results The levels of TNF-α,IL-8 and IL-6 in patients group were significantly higher than those in control group ( P 〈0.05 ).The expression levels of BCRP and MRP5 mRNA were significantly increased,as compared with those in control group ( P 〈0.05),however,there were no significant differences in the other kinds of MRP between two groups ( P 〉0.05).Conclusion The increase of proinflammatory factors in peripheral blood of patients with breast cancer may be correlated to the expressions of BCRP and MRP 5,however,the related mechanism needs to be studied further .
出处 《河北医药》 CAS 2015年第2期176-179,共4页 Hebei Medical Journal
关键词 乳腺肿瘤 外周血 单个核细胞 多药耐药相关蛋白 breast neoplasms peripheral blood PBMCs MRP
  • 相关文献

参考文献2

二级参考文献44

  • 1杨纯正,栾凤君,熊冬生,刘炳仁,许元富,顾孔书.阿霉素诱导的人白血病细胞系K562/A02多药抗药性(英文)[J].中国药理学报,1995,16(4):333-337. 被引量:23
  • 2Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res, 1970; 30 (4): 1174- 1184.
  • 3Garcia MG, Alaniz L, Lopes EC, et al. Inhibition of NF-kappaB activity by BAY11-7082 increases apoptosis in multidrug resistant leu- kemic T-cell lines. Leuk Res, 2005 ; 29(12) : 1425 - 1434.
  • 4Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 1986 ; 46(5) : 705 - 716.
  • 5Um JH, Kang CD, Lee BG, et al. Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance. Oncogene, 2001 ; 20(42) : 6048 - 6056.
  • 6Garcia MG, Alaniz LD, Cordo Russo RI, et al. PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leuk Res, 2009; 33(2) : 288 -296.
  • 7Bentires-Alj M, Barbu V, Fillet M, et al. NF-kappaB transcription factor induces drug resistance through MDRI expression in cancer cells. Oncogene, 2003 ; 22 ( 1 ) : 90 - 97.
  • 8Tsuruo T, Iida H, Tsukagoshi S, et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res, 1981; 41(5) : 1967 -1972.
  • 9Guo F, Sun A, Wang W, et al. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells. Mol immunol, 2009; 46( 13): 2441 - 2448.
  • 10Sandur SK, Deorukhkar A, Pandey MK, et al. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys, 2009 ; 75 ( 2 ) : 534 - 542.

共引文献28

同被引文献44

  • 1Vlaming ML, Teunissen SF, van de Steeg E, et al. Bcrpl ; Mdrl a/b ; MIp2 combination knockout mice:altered disposition of the dietary carcinogen PhIP ( 2-amino-l-methyl-6-phenylimidazo [ 4,5-b ] pyri- dine) and its genotoxic metabolites [ J ]. Mol Pharmacol, 2014,85 (3) :520-530.
  • 2Andersen V,Vogel LK,Kopp TI,et al. High ABCC2 and low ABCG2 gene expression are early events in the eolorectal adenorna-careinoma sequence [ J ]. PLoS One,2015,10 ( 3 ) : e0119255.
  • 3Ohya, H, Shibayama ~, Ogura J, et al. Regorafcnih is transported by the organic anion transporter 1BI and the muhidrug resistance pro- tein 2 [ J 1- Biol Pharm Bu11,2015,38 (4) :582 - 586.
  • 4Wissel G, Kudryavtsev P, Ghemtio L, ct al. Exploring the structure - activity relationships of ABCC2 modulators using a screening ap- proach[ Jl- Bioorg Med Chem,2015,23 ( 13 ) :3513 - 3525.
  • 5H~iussinger D, Schmittv M, Weiergriiberv O, et al. Short-term regula- tion of canalicular transport [ J 1. Semin Liver Dis, 2000,20 ( 3 ) : 307 -321.
  • 6Nguyen TD, Markova S, Liu W, et al. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression [ J 1. Pharmacogenomics J,2013,13 (5) : 396 - 402.
  • 7Zhang Y, Zhao T, Li W, et al. The 5 '-untranslated region of multidrug resistance associated protein 2 ( MRP2, ABCC2) regulates downstream ()pen reading frame expression through translational regulation [ J l- Mol Pharmocol,2010,77 (2) :237 - 246.
  • 8Li M,Wang W,Soroka CJ,et al. NHERF-1 binds to Mrp2 and regu- lates hepatic Mrp2 expression and function[J~. J Biol Chem,2010, 285 ( 25 ) : 19299 - 19307.
  • 9Lee YK, Lin TH, Chang CF, et al. Galectin-3 silencing inhibits epiru- bicin-induced ATP binding cassette transporters and activates the mi- tochondrial apoptosis pathway via [3-Catenin/GSK-3[3 modulation in colorectal carcinoma[ J 1. PLoS One ,2013,8 ( 11 ) : e82478.
  • 10Timerbaev AR, Hartinger CG, Aleksenko SS,et al. Interactions of an- titumor metallodrugs with serum proteins : advances in characterization using modern analytical methodology [ J ]. Chem Rev,2006,106 (6) : 2224 - 2248.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部